Improvements in disease severity and quality of life measures among adults with psoriasis who are receiving apremilast was independent of genital psoriasis involvement. Apremilast improves disease ...

Please provide your email address to receive an email when new articles are posted on . Regardless of body surface area involvement, apremilast showed consistent improvement in genital psoriasis vs.

Genital psoriasis can cause red or purple lesions that may be itchy and painful. Treatments include topical corticosteroids ...

Arcutis Biotherapeutics has published 14 consensus statements developed by the Genital Psoriasis Wellness Consortium, a group of experts aimed at improving the understanding and management of genital ...

Arcutis convened the Genital Psoriasis Wellness Consortium, a multidisciplinary group of clinicians who are experts in their fields Publication includes 14 consensus statements aimed at improving ...

In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ...

66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational icotrokinra achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to ...

In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in Phase 3 ...